Results 151 to 160 of about 58,392 (301)

Radionuclide therapy of hepatocellular carcinoma

Biomedical Imaging and Intervention Journal, 2006
Hepatocellular carcinoma (HCC) is a malignant tumour of the hepatocyte. It is a common malignancy worldwide and causes almost half a million deaths annually. Asia is a high risk area. Although surgery (hepatectomy or liver transplantation) is the main form of curative treatment, the majority of patients are not eligible for surgery due to extent of ...
openaire   +2 more sources

Small Bowel Obstruction due to Meckel's Diverticulum: A Case Report

Clinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Meckel's diverticulum should be considered in cases of unexplained small bowel obstruction, especially in pediatric and adolescent patients. Early recognition and timely surgical intervention can prevent complications and lead to favorable outcomes.
Mansab Ali, Amir Usman, Shahr Yar, Bilal Aslam, Salman Ghulam Nabi, Seemab Ara, Dawood Azam Farooq, Aiman Tanveer, Sheraz Arshad, Nour Fakih, Muhammad Imran   +10 more
wiley   +1 more source

Necrolytic Migratory Erythema as the First Manifestation of Functional Conversion in a Glucagonoma: A Case Report

Clinical Case Reports, Volume 13, Issue 12, December 2025.
ABSTRACT Necrolytic migratory erythema is a characteristic but often underrecognized manifestation of glucagonoma. Its timely identification can lead to early diagnosis and curative surgery of pancreatic neuroendocrine tumors that initially present as clinically silent lesions.
Matheus Felipe Ferreira Aguiar, Jose Jukemura   +1 more
wiley   +1 more source

Mechanisms, impacts and therapeutic strategies of glucose metabolic reprogramming in tumours

Clinical and Translational Discovery, Volume 5, Issue 6, December 2025.
Tumour metabolic reprogramming initiates a vicious cycle of immunosuppression and therapy resistance. This synergy disarms immunity and fortifies tumour cells, ultimately driving clonal evolution of resistant disease. Abstract Background Glucose metabolic reprogramming is a hallmark of cancer, best exemplified by the Warburg effect.
Li Ma, Ming‐yang Wu, Cui‐cui Tian, Hao‐ze Shi, Dan Song   +4 more
wiley   +1 more source

Factors Associated with Risk of Clonal Haematopoiesis of Indeterminate Potential: A Systematic Review and Meta‐Analysis

eJHaem, Volume 6, Issue 6, December 2025.
ABSTRACT Introduction Clonal haematopoiesis of indeterminate potential (CHIP) is a risk factor for blood cancers and non‐haematological diseases. Understanding factors that lead to CHIP is essential in developing preventive strategies. We aimed to identify factors associated with risk of CHIP through a systemic literature review.
Jasmine Singh, Nancy Li, Elham Ashrafi, Le Thi Phuong Thao, David J. Curtis, Erica M. Wood, Zoe K. McQuilten   +6 more
wiley   +1 more source

Efficacy of Radioimmunotherapy for Malignant Lymphoma; Further Possibility of Molecular Targeted Radionuclide Therapy in Oncology

, 2012
Masatoshi Hasegawa
openalex   +1 more source

Radiation‐Induced Biological Effects: Molecular and Cellular Mechanism, and Applications to Radiation/Nuclear Emergency and Cancer Therapy

MedComm, Volume 6, Issue 12, December 2025.
Radiation‐induced biological effects are an extremely complex and extensive mechanism that involves multiple aspects of physiological activities in organisms. In the medical field, utilizing the damaging effects of radiation to treat tumors is a commonly employed therapeutic approach.
Zhihe Hu, Yan Chen, Shengyi Yang, Shihai Diao, Le Ma, Chunmeng Shi   +5 more
wiley   +1 more source

An absorbed dose‐based source strength determination for diffusing alpha‐emitters radiation therapy (DaRT) brachytherapy seeds – Proof of concept

Medical Physics, Volume 52, Issue 12, December 2025.
Abstract Background Diffusing alpha‐emitter radiation therapy (DaRT) is currently being evaluated in several clinical trials as an interstitial temporary brachytherapy source. However, determining source strength solely based on gamma spectrometry measurements of 224Ra activity has limitations. This method does not account for changes in the desorption
Sean P. Jollota, Jeffrey L. Radtke, Larry A. DeWerd, Ahtesham Ullah Khan   +3 more
wiley   +1 more source

Lead-212 Radiopharmaceuticals for Receptor-Targeted Radionuclide Therapy [PDF]

Journal of Mazandaran University of Medical Sciences
Receptor-targeted radionuclide therapy (RTRT) combines the power of particle-emitting radionuclides with the receptor-targeting capabilities of biomolecules, including antibodies and peptides.
Solmaz Mojarad-Jabali, Sajjad Molavipordanjani   +1 more
doaj  

Fully human monoclonal antibodies and targeted radionuclide therapy [PDF]

, 2008
Tod W. Speer
openalex   +1 more source